We’re thrilled to announce that Michael Hund, MBA, CEO of EB Research Partnership, will deliver the Keynote Presentation at the upcoming SMART CRC Launch Event!
Michael is a globally recognised leader in venture philanthropy, impact investing, and medtech entrepreneurship. His work has been featured by MIT, Yale, Harvard, Stanford, Cambridge, Forbes, and the Milken Institute. At EBRP, he has led the charge in raising over $70 million, expanding clinical trials, and accelerating 3 FDA-approved treatments for rare diseases (for more information, please see Michael’s full bio below).
Michael’s inspirational speaking and visionary leadership were instrumental during the SMART CRC bid process – his message helped shape the culture and foundation that now guide the Centre’s vision. We’re excited to welcome him to Australia to share his insights on purpose-driven innovation in biomedical research, and to inspire the broader SMART CRC community. Stay tuned to hear more about this philosophy and the story behind it at the launch event.
MICHAEL HUND, MBA
CHIEF EXECUTIVE OFFICER
Michael Hund, MBA, is an award winning CEO with more than 20 years of experience in the innovative business models of venture philanthropy, impact investing and medtech entrepreneurship. His leadership has been highlighted by MIT, Yale, Harvard, Stanford, Cambridge, Forbes, and the Milken Institute.
He is the CEO of EB Research Partnership, a game changing medical research organization dedicated to curing EB and scaling their model to rare disease. Under his leadership EBRP has raised more than $70 million to transform the landscape from 2 to over 50 clinical trials and accelerated 3 FDA approved treatments. He is Executive Producer of the documentary Matter of Time, premiering at the Tribeca Film Festival in 2025 and Executive Producer of Venture into Cures, combining stories of the patient and medical communities with musicians and actors to raise more than $12 million. Previously he served as the Director for the Multiple Myeloma Research Foundation and Paul Newman’s Hole in the Wall Gang, working on behalf of children battling life threatening illnesses.
Michael received his MBA from Yale University, CORe credential from Harvard Business School, and a degree in Philosophy from the University of Kansas. He is the recipient of the MIT Solve Innovation Award, iHeart Media’s CEOs You Should Know, the Milken Institute’s Changemaker and LeadersLink, Social Innovations Journal Leadership Award, Top 100 Magazine Innovators, and IAOTP’s Top CEO of the Year in Medical Research.